Fibromyalgia: The Answer Is Blowin' in the Wind

Journal of Rheumatology

Volumn 31, Issue 4, 2004, Pages 636-639

  White, Kevin P ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CHRONIC PAIN; EDITORIAL; FIBROMYALGIA; HUMAN; HYPOTHYROIDISM; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SKIN TEMPERATURE; SYMPTOMATOLOGY;

CLINICAL COMPETENCE; FIBROMYALGIA; HUMANS; PROFESSIONAL PRACTICE;

EID: 1842425917     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (42)

1. Ochoa JL. Essence, investigation, and management of " neuropathic" pains: hopes from acknowledgement of chaos. Muscle Nerve 1993;16:977-1008.
2. Hart FD. Fibrositis (fibromyalgia): A common non-entity? Drugs 1988;35:320-7.
3. Gardner M. Fads and fallacies in the name of science. New York: Dover; 1957:86.
4. Hadler NM. The danger of the diagnostic process. In: Hadler NM, editor. Occupational musculoskeletal disorders. New York: Raven; 1993:16-33.
5. Block DR. Fibromyalgia and the rheumatisms. Common sense and sensibility. Rheum Dis Clin North Am 1993;19:61-78.
6. Anderson KN, Anderson LE, Glanze WD, editors. Mosby's medical, nursing and allied health dictionary. 4th ed. St. Louis: Mosby Year Book; 1994.
7. Dorland's medical dictionary. Philadelphia: W.B. Saunders; 1994.
8. Granges G, Littlejohn GO. A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy and exercising subjects. J Rheumatol 1993;20:344-51.
9. Moldofsky H. Sleep and fibrositis syndrome. Rheum Dis Clin North Am 1989;15:91-103.
10. Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001; 44:222-30.
11. McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome. A comparison with rheumatoid arthritis. J Rheumatol 1989;16 Suppl 19:154-7.
12. Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 1992;35:1113-6.
13. Yunus MB, Dailey JW, Aldag DC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia: A controlled study. J Rheumatol 1992;19:90-4.
14. Russell IJ, Vaeroy H, Javors M, et al. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35:550-6.
15. Vaeroy H, Helle R, Forre O, Kass E, Terenius L. Elevated CSF levels of substance P and high incidence of Raynaud's phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988;32:21-6.
16. van West D, Maes M. Neuroendocrine and immune aspects of fibromyalgia. BioDrugs 2001;15:521-31.
17. Hau PP, Scudds RA, Harth M. An evaluation of mechanically induced neurogenic flare by infrared thermography in fibromyalgia. J Musculoskel Pain 1996;4:3-20.
18. Qiao Z, Vaeroy H, Morkrid L. Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests. J Rheumatol 1991;18:1383-9.
19. Martinez-Lavin M, Hermosillo AG, Mendoza C, et al. Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol 1997;24:714-8.
20. Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-38.
21. Bradley LA, Alberts KR, Alarcon GS, et al. Abnormal brain regional cerebral blood flow (rCBF) and cerebrospinal fluid (CSF) levels of substance P (SP) in patients and non-patients with fibromyalgia (FM) [abstract]. Arthritis Rheum 1996;39 Suppl:S212.
22. Irwin M, Clark C, Kennedy B, Christian Gillin J, Ziegler M. Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain Behav Immun 2003;17:365-72.
23. Jozuka H, Jozuka E, Takeuchi S, Nishikaze O. Comparison of immunological and endocrinological markers associated with major depression. J Int Med Res 2003;31:36-41.
24. Maddock C, Pariante CM. How does stress affect you? An overview of stress, immunity, depression and disease. Epidemiol Psychiatr Soc 2001;10:153-62.
25. Raison CL, Miller AH. The neuroimmunology of stress and depression. Semin Clin Neuropsychiatry 2001;6:277-94.
26. Tomassini C, Rosina A, Billari FC, Skytthe A, Christensen K. The effect of losing the twin and losing the partner on mortality. Twin Res 2002;5:210-7.
27. Martikainen P, Valkonen T. Mortality after the death of a spouse: rates and causes of death in a large Finnish cohort. I. Am J Public Health 1996;86:1087-93.
28. Smith KR, Zick CD. Risk of mortality following widowhood: age and sex differences by mode of death. Soc Biol 1996;43:59-71.
29. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
30. Brena SR, Chapman SL: The 'learned pain syndrome': Decoding a patient's pain signals. Postgrad Med 1981;69:53-64.
31. Chapman SL, Brena SR. Learned helplessness and responses to nerve blocks in chronic low back patients. Pain 1982;14:355-64.
32. White KP, Nielson WR, Harth M, Speechley M, Ostbye T. Does the label 'fibromyalgia' alter health status and function? A prospective, within-group comparison [abstract]. Arthritis Rheum 2000;43 Suppl:S212.
33. Farooqi A, Gibson T. Prevalence of the major rheumatic disorders in the adult population of north Pakistan. Br J Rheumatol 1998;37:491-5.
34. The epidemiology of fibromyalgia: Workshop of the Standing Committee of Epidemiology, European League Against Rheumatism (EULAR), Bad Sackingen, 19-21 November 1992. Br J Rheumatol 1994;33:783-6.
35. Lyddell C, Meyers OL. The prevalence of fibromyalgia in a South African community [abstract]. Scand J Rheumatol 1992;Suppl 94:8.
36. Jacobsson L, Lindegard F, Manthorpe R. The commonest rheumatic complaints over a 6 weeks' duration in a twelve month period in a defined Swedish population. Scand J Rheumatol 1989;18:361-8.
37. Prescott E, Kjoller M, Jacobsen S, Bulow PM, Danneskiold-Samsoe B, Kamper-Jorgensen F. Fibromyalgia in the adult Danish population: I. A prevalence study. Scand J Rheumatol 1993; 22:233-7.
38. Makela M, Heliovaara M. Prevalence of primary fibromyalgia in the Finnish population. BMJ 1991;303:216-9.
39. Ehrlich GE. Pain is real; fibromyalgia isn't. J Rheumatol 2003;30:1666-7.
40. Hadler NM. "Fibromyalgia" and the medicalization of misery. J Rheumatol 2003;30:1668-70.
41. Wolfe F. Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol 2003;30:1671-2.
42. Russell AS, Percy JS. Disabling fibromyalgia: appearance vs reality [letter]. J Rheumatol 1994;21:1580.